BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25555268)

  • 1. Circulating gamma glutamyltransferase and prediction of cardiovascular disease.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Feb; 238(2):356-64. PubMed ID: 25555268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study.
    Kunutsor SK; Bakker SJL; Dullaart RPF
    J Atheroscler Thromb; 2017 Aug; 24(8):804-818. PubMed ID: 28202840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
    Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
    J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults.
    Ruttmann E; Brant LJ; Concin H; Diem G; Rapp K; Ulmer H;
    Circulation; 2005 Oct; 112(14):2130-7. PubMed ID: 16186419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies.
    Kunutsor SK; Bakker SJ; James RW; Dullaart RP
    Atherosclerosis; 2016 Feb; 245():143-54. PubMed ID: 26724525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Blokzijl H; Gansevoort RT; Dullaart RP
    Atherosclerosis; 2015 Nov; 243(1):138-47. PubMed ID: 26386210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamyltransferase and Risk of Sudden Cardiac Death in Middle-Aged Finnish Men: A New Prospective Cohort Study.
    Kunutsor SK; Khan H; Laukkanen JA
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma calprotectin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
    Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
    Atherosclerosis; 2018 Aug; 275():205-213. PubMed ID: 29957458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events. The REGICOR study.
    Velescu A; Clara A; Peñafiel J; Ramos R; Marti R; Grau M; Dégano IR; Marrugat J; Elosua R;
    Atherosclerosis; 2015 Aug; 241(2):357-63. PubMed ID: 26071658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
    Wannamethee SG; Lennon L; Shaper AG
    Atherosclerosis; 2008 Nov; 201(1):168-75. PubMed ID: 18378241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyltransferase, cardiovascular disease and mortality in individuals with diabetes mellitus.
    Sluik D; Beulens JW; Weikert C; van Dieren S; Spijkerman AM; van der A DL; Fritsche A; Joost HG; Boeing H; Nöthlings U
    Diabetes Metab Res Rev; 2012 Mar; 28(3):284-8. PubMed ID: 22144398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gamma-Glutamyltransferase predicts cardiovascular death among Japanese women.
    Hozawa A; Okamura T; Kadowaki T; Murakami Y; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Okayama A; Ueshima H;
    Atherosclerosis; 2007 Oct; 194(2):498-504. PubMed ID: 17034795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies.
    Kunutsor SK; Apekey TA; Khan H
    Atherosclerosis; 2014 Sep; 236(1):7-17. PubMed ID: 24998934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein.
    Kunutsor SK; Bakker SJ; Kootstra-Ros JE; Gansevoort RT; Gregson J; Dullaart RP
    PLoS One; 2015; 10(7):e0132822. PubMed ID: 26167920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma-glutamyltransferase and cardiovascular mortality in Korean adults: A cohort study.
    Yi SW; Lee SH; Hwang HJ; Yi JJ
    Atherosclerosis; 2017 Oct; 265():102-109. PubMed ID: 28881267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating total bilirubin and risk of incident cardiovascular disease in the general population.
    Kunutsor SK; Bakker SJ; Gansevoort RT; Chowdhury R; Dullaart RP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):716-24. PubMed ID: 25593130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population.
    Meisinger C; Döring A; Schneider A; Löwel H;
    Atherosclerosis; 2006 Dec; 189(2):297-302. PubMed ID: 16483579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.